abstract
- The capacity of the endothelium to release tissue-type plasminogen activator (t-PA) is markedly impaired in adults with obesity underlying their increased thrombotic risk. Circulating endothelial cell-derived microvesicles (EMVs) are systemic modulators of vascular health and disease; and are elevated with obesity. The experimental aim of this study was to determine whether circulating EMVs are associated with obesity-related endothelial fibrinolytic dysfunction. Twenty-eight sedentary, midlife and older adults (45-71 years) were studied: 14 normal weight (7M/7F; age: 55±4 yr; BMI: 23.1±1.6 kg/m2) and 14 obese (7M/7F; 57±8 yr; 31.9±2.9 kg/m2). EMV identification (CD144+) and concentration in peripheral blood were determined by flow cytometry. Endothelial release of t-PA was determined, in vivo, in response to intra-brachial infusions of bradykinin (BK: 125-500 ng/min) and sodium nitroprusside (SNP: 2.0-8.0 µg/min). Circulating EMV levels were ~170% higher (P<0.001) in obese (183±58 EMV/μL) compared with normal weight (68±12 EMV/μL) adults. Endothelial t-PA release in response to BK was significantly lower (~30%) in the adults with obesity (from 0.7±3.6 to 35.9±15.1 ng/100mL tissue/min) vs normal weight adults (-0.5±2.3 to 68.4±21.1 ng/100mL tissue/min). Consequently, total t-PA release (area under the BK curve) was lower (~35%; P=0.007) in the adults with obesity (205±118 ng/100mL tissue vs 325±97 ng/100mL tissue). Circulating EMVs were significantly and inversely associated with both peak t-PA release (r=-0.67; P<0.001) and total t-PA release to BK (r=-0.53; P=0.003). In summary, obesity-related increase in circulating EMVs is associated with diminished endothelial t-PA release. Circulating EMVs may serve as a biomarker of fibrinolytic dysfunction in adults with obesity.